glp-1 treatment gonzales GLP Weight Loss Medications How GLP-1 medications are transforming
Description
Kidney and liver function As semaglutide binds strongly to albumin and is cleared slowly, any liver or kidney disease may influence clearance time
Retatrutide (research phase) Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors
Whos included: Those diagnosed with gastroparesis (delayed stomach emptying)
When released, it helps increase the secretion of insulin and reduce glucagon
The gut microbiome helps process fiber and produces compounds that influence hormone signaling, inflammation, and metabolism
